Murine placentation is associated with the invasion of maternal endometrium by trophoblasts and an extensive maternal and foetal angiogenesis. Plasminogen activator inhibitor-1 (PAI-1) is transiently produced by spongiotrophoblasts and trophoblast giant cells at 10.5-11.5 day postcoitum (dpc). Knowing the key contribution of PAI-1 in the regulation of angiogenesis, we have now analyzed the consequence of PAI-1 deficiency on murine placentation. Morphological and quantitative computer-assisted image analysis revealed abnormal placental morphology in PAI-1 -/-mice at 10.5 and 12.5 dpc. At 10.5 dpc, the genetic ablation of PAI-1 resulted in a transient reduction of both maternal and foetal vascularizations in the placenta and increased trophoblast cell density. This was associated with a poorer development of the labyrinth and an extension of the decidua. A larger spongiotrophoblast layer appeared at 12.5 dpc in PAI-1 deficient mice.
INTRODUCTION
Extensive maternal and foetal vascular remodellings during placentation result in a large network of closely apposed but separated maternal and foetal circulations (24) . The maternal uterine vascular bed changes dramatically during pregnancy as existing vessels dilate and new vessels form (13) . In addition, in primates and rodents, terminal vascular bed is not lined by endothelial cells but is rather hemochorial, meaning that maternal blood perfuses a space lined by trophoblast cells. Failure in placental angiogenesis can lead to pregnancy disorders, including miscarriages, foetal growth restriction and preeclampsia (8) .
The precise molecular mechanisms that regulate maternal vascular development during gestation and its relationship to foetoplacental development are largely unknown. Adequate placentation involves successful invasion of uterine decidua by primary and secondary trophoblast cells. These cells express several factors with potent angiogenic (e.g., VEGF, Proliferin) and vasoactive (e.g., nitric oxide, Adrenomedullin) effects (13) . Their invasive property is associated with their capacity to secrete serine proteases (plasminogen/plasmin), matrix metalloproteinases (MMPs) and cathepsins that degrade the extracellular matrix (37; 45) .
A functional synergism of both serine proteases and MMPs regulates vascularisation during placental development (48) .
The plasminogen/plasmin system consists of an inactive proenzyme, plasminogen which is converted into plasmin by urokinase-type plasminogen activator (uPA) or tissue-type plasminogen activator (tPA). Plasminogen activator inhibitor-1 (PAI-1) is a primary uPA regulator which inhibits uPA by forming a covalent complex, thus controlling the thrombotic/fibrinolytic process (7; 39) . In addition, through its binding to the extracellular matrix (ECM), PAI-1 regulates cell adhesion and migration by interfering with the binding between cellular integrins or uPA receptor (uPAR) and vitronectin (16) . 4 The key role of PAI-1 in angiogenesis associated to cancer progression is well documented. In vivo experiments revealed that: (1) pharmacological PAI-1 levels prevent angiogenesis and tumorigenesis; (2) physiological PAI-1 levels inversely facilitate tumour growth and angiogenesis, and (3) tumour growth and angiogenesis are impaired in the absence of PAI-1 in mice (3; 20; 36) . We have shown in several in vivo and in vitro models of angiogenesis that such angiogenic property of PAI-1 results from its ability to inhibit plasmin and thereby to protect endothelial cells from excessive proteolytic degradation (2-4; 20; 33; 39) and/or apoptosis (5) . Based on the similarities between tumor cell invasion and trophoblast invasion (49) , we extended our study by investigating the putative function of PAI-1 during physiological placentation through a genetic approach. Intriguing findings are the observations that PAI-1 knockout mice are fertile and that their litter sizes are normal (11) . During implantation, PAI-1 is produced specifically by spongiotrophoblasts and trophoblast giant cells at days 10.5-11.5 dpc (50) . The cell specific and timely regulated expression of PAI-1 in placenta, suggest that it might play a significant role, during early phases of placental vascular remodelling. In the present study, we explored the putative role of PAI-1 during mouse placentation by analysing the vasculature and morphology of placenta at 10.5, 12.5 and 14.5 dpc in PAI-1 mice deficient or in their control counterparts. In order to evaluate gene expression modulation associated to PAI-1 deficiency, laser capture microdissection (LCM) of labyrinth from PAI-1 +/+ and PAI-1 -/-mice followed by microarray analysis were carried out. We provide evidence for a transient perturbation of placental morphology associated with a deregulation at the transcript levels of murine cathepsin family members. 
MATERIALS AND METHODS

Transgenic mice
Homozygous mice with a single gene deficiency (PAI-1 -/-) and the corresponding wild type animals (PAI-1 +/+ ) were previously described (11) . To generate homozygous embryos in mothers of the same genotype, homozygote knockout and WT females with proven fertility were mated with homozygotes knockout and WT males, respectively. Pregnancy was checked by occurrence of vaginal plugs in the morning. The day of vaginal copulation plug detection was designated as day 0.5 post-coitum (dpc). Embryos were collected at 10.5, 12.5 and 14.5 dpc. At each time point, 6 to 9 embryos were obtained from three different females.
Tissue preparation
At sacrifice, the two uterine horns were removed to isolate and separate the different fetoplacental units. Length and width of each of them were measured just after dissection. The fetoplacental units of first horn were fixed in 10% formaldehyde for 1 hour, at room temperature.
Dehydration was achieved by incubating embryos, 2 times for 1 hour in increasing concentrations of alcohol (70% to 95% ethanol) followed by isopropanol and xylol. Specimens were then embedded in Paraplast Plus (Labonord, Rekkem, Belgium). The feto-placental units of second horn were embedded in Tissu-Teck (Labonord), snap frozen in liquid nitrogen, and stored at -80 o C until use.
Histological analysis
Serial sections (5 µm thick) were stained with Hematoxylin and Eosine or May-Grünwal- min at room temperature and detected with ARK system (K3954, DAKO) (9; 26). The DAB system was used for final staining.
Panendothelial cell "MECA32" Ab (75861E, Pharmingen, San Jose, CA, USA ) was used to identify both maternal and foetal blood vessels (6) . 
Quantification of trophoblast, foetal and maternal blood vessel density
Image processing was performed by using Aphelion3.2 (Adsis, Meythet, France)
software. Images were registered in the RGB color space, in which maternal erythrocytes appeared red whereas foetal red cells were colored as mauve dots and trophoblast cells as purpleblue regions (Fig. 1a) . Area of region of interest was manually delineated by drawing (Fig. 1b) .
Two windows were drawn manually in order to discriminate between maternal ( 
Morphometric analysis of labyrinth and decidua thickness
Different zones including the labyrinth, the spongiotrophoblast, trophoblast giant cells and maternal decidua, were identified in hematoxylin-eosine stained sections. The widths of labyrinth, spongiotrophoblast and decidua were determined by drawing a line parallele to the basis of the labyrinth, identifying the midpoint of this line, and then extending a perpendicular line first to the outer edge of the spongiotrophoblast (junctional zone) and then up to the peripheral edge of the decidua (Fig. 2 G) . These measures were used to determine the ratios between decidua/labyrinth and spongiotrophoblast/labyrinth.
For these measurements, microscopic images of feto-placental sections stained with hematoxylineosine were acquired via a numerical camera (Nikon, Coolpix 990, Tokyo, Japan) with identical magnification. For each sample, whole implantation site with the embryo in situ was cut and morphometric measurement was performed on 5 sections chosen in the extremities and the middle part of the placenta using the IMAGE J software. The average of these five values was determined for each implantation site.
Laser Pressure Microdissection (LCM) and RNA extraction
In order to isolate the labyrinth layer, 10 µm of foeto-placental frozen sections were carried 
Transcriptome analysis
For microarray study, RNA pools were used and contained equal amount of RNA from the labyrinth layer of 3 mice per conditions [(1) PAI-1 +/+ at 10.5 dpc, (2) PAI-1 -/-at 10.5 dpc, (3) PAI-1 +/+ at 14.5 dpc and (4) 
cDNA synthesis and RT-PCR
For cDNA synthesis, 1µg of total RNA was reverse transcribed with a Super Script First
Strand Synthesis System (Invitrogen, Carslbad, USA) and random hexamers as primers.
cathepsine 3 (Cts3), cathepsine M (CtsM), cathepsine 8 (Cts8), cathepsine E (CtsE), pregnancyspecific-glycoprotein 19, 21 and 28 (Psg), prolactin-like protein F (PrlpF), trophoblast specific protein beta (Tpbpb) and fms-like tyrosine kinase 1 (Flt-1) RNA and 28S ribosomal RNA (rRNA) were measured in 10 ng aliquots of cDNA using Taq polymerase (Takara, Shiga, Japan) and 5 pmoles of specific primers (Eurogentec, Seraing, Belgium). Primers, amplification tempter and cycle's number used for each gene are listed in Table 1 . The thermal cycling included 2 min. at 95°C for denaturation and then amplification 15 sec. at 94°C, 20 sec at specific amplification tempeture (Table1) and then 20 sec. at 72°C with a final incubation 2 min. at 72°C. RT-PCR products were resolved on 10% polyacrylamide gels and analysed using a LAS-4000 Imaging (FujiFilm) after staining with Gelstar dye (FMC BioProduct, Rockland, ME, USA). mRNA products were quantified by normalization with respect to 28S rRNA. RT-PCR was performed in duplicate for each sample.
Statistical analysis
For histological investigations, data were analyzed by using GraphPad 4.0 software (San Diego, CA). A Mann-Withney test was used to determine if difference between experimental groups could be considered as significant. For microarray, the raw P values were adjusted by the Bonferroni method, which controls the Family Wise Error Rate (FWER) (22). The level of statistical significance was set at 0.05 for all the comparisons.
RESULTS
3.1-Maternal and foetal vascularisations are reduced in PAI-1 -/-mice at 10.5 dpc
Since placental PAI-1 expression is restricted to days 10.5-11.5 dpc (50) we first examined PAI-1 +/+ and PAI-1 -/-implantation sites at 10.5 dpc when embryonic and maternal placental vessels invade the labyrinth. Placental circulation was assessed by the presence of vessels containing nucleated foetal erythrocytes stained in mauve by MGG ( Fig. 2A) . Remodeled maternal vessels where endothelial cells were substituted by trophoblast cells, were characterized by their content in red enucleated erythrocytes ( Fig. 2A) . Maternal and embryonic circulations were in close proximity in the labyrinth layer ( Fig. 2A ) which was composed of thin strands of trophoblast cells positive for keratin (Fig. 2C ) intermingled with extensive networks of foetal and maternal vessels. In PAI-1 -/-mice, the labyrinth was characterized by a dense network of thicker strands of keratin positive trophoblastic cells (Fig. 2D ) which were poorly infiltrated by maternal and embryonic vessels (Fig. 2B ).
Both foetal and maternal blood vessel densities were significantly reduced in PAI-1 deficient mice in comparison to WT mice (p< 0.02) (Figs. 3A, B) . In addition, a 35% increase of trophoblast cell density was noted in PAI-1 -/-mice (p= 0.0047) (Fig. 3C) . Immunostaining of foetal and maternal blood vessels by using an anti-MECA-32 Ab confirmed the reduction of blood vessel number and confirmed the reduced development of the labyrinth in PAI-1 -/-mice (Fig. 2E, F) . No difference was seen in spongiotrophoblast layer between these two groups of mice.
3.2-
The labyrinth is poorly developed and the decidual layer is extended in PAI-1 -/-mice at
dpc
The decidua identified with an anti-desmin antibody appeared larger in PAI-1 -/-mice than in WT animals (Figs. 2G, H) . A quantitative morphometric assessment of relative labyrinth and decidua thickness confirmed the relative poorer development of the labyrinth and the higher extension of the decidual layer in PAI-1 -/-mice. The decidua/labyrinth ratio was 2.3-fold higher in PAI-1 -/-than in their WT counterpart (Fig. 3D ). This increased ratio was related to a thicker decidua and a thinner labyrinth layer in PAI-1 -/-mice (p=0.0002). This is presumably the consequence of a decreased decidual invasion by trophoblast cells.
Ki-67 immunohistochemistry, revealed that PAI-1 -/-placentas presented a larger area or patches of Ki67 positive cells at the labyrinth layer comparing to PAI-1 +/+ placentas (Fig.2I, J ).
This finding confirms that reduction of labyrinth layer in the absence of PAI-1 is correlated to differentiation delay of trophoblast cells.
3.3-The labyrinthic vascularization is restored with a larger spongiotrophoblast layer in
PAI-1 -/-mice at 12.5dpc
At day 12.5, when placental PAI-1 is no longer expressed, important differences appeared in the spongiotrophoblast (Fig. 4A, B) . In PAI-1 -/-mice, spongiotrophoblast appeared much denser with more trophoblast cells and less lacunar structures, leading to an increased thickness (Fig. 4B) . Morphometric measurement revealed a 34% increased spongiotrophoblast/labyrinth ratio in PAI-1 -/-mice (Fig. 5A) . The relative decidua/labyrinth ratio was again more important in placental morphology in PAI-1 deficient mice. This observation demonstrates that the lack of PAI-1 transiently affected placental morphology and vascularisation which is then followed by a normalization of placental structure between 12.5 and 14.5 dpc.
3.5-Phenotype observed at 10.5 dpc in PAI-1 -/-mice is associated with gene modulation
To assess the molecular basis of the impaired angiogenesis observed in PAI-1deficient mice, we performed a transcriptomic profiling using the Affymetrix Mouse Genome 430 2.0 chips (34,000 genes) in the labyrinth layer of PAI-1 +/+ and PAI-1 -/-at 10.5 and 14.5 dpc. This microarray analysis revealed that more genes were significantly modulated during the course of pregnancy by comparing 10.5 dpc to 14.5 dpc than when comparing the two genotypes at identical lengths of pregnancy. Indeed, the comparison of gene expression between 10.5 dpc and 14.5 dpc revealed that 496 genes were differentially expressed in PAI-1 +/+ mice and 210 in PAI-1 -14 /-mice. Among those genes, 159 were co-expressed in the two genotypes ( Figure 6A ). When comparing PAI-1 proficient and deficient mice at the early time point, i.e. at 10.5 dpc when specific alteration of the labyrinth layer was histologically observed, only 46 genes were differentially expressed between PAI-1 +/+ and PAI-1 -/-( Figure 6B ). Later on, at 14.5 dpc, when placental morphology was normalized, only 8 of these 46 genes were still differently regulated between the two genotypes. In addition, two additional genes appeared differently expressed at this latter time point. Features of the identified gene profile in PAI-1-deficient mice at 10.5dpc
are that (1) most are related to molecules specifically expressed in the murine placenta ( . In sharp contrast, such a differential regulation between the two genotypes was not anymore detected at 14.5 dpc (mRNA ratio around 1) (Fig.7) , further supporting the normalization of placental features at this time point.
DISCUSSION
PAI-1 contribution in pathological processes associated to abnormal angiogenesis such as cancer and age-related macular degeneration is well documented (4; 25; 33), but its function during the remodeling of maternal tissues associated with human embryo implantation is not yet fully determined (21; 28; 45) . In mice, PAI-1 is essentially produced by spongiotrophoblast and trophoblast giant cells at days 10.5-11.5 dpc (50). Through a genetic approach, we tested the hypothesis that PAI-1, which is a key regulator of pathological angiogenesis could contribute to the control of placental angiogenesis. We provide, for the first time, evidence that PAI-1 gene deletion transiently affects the process of placentation.
The lack of PAI-1 resulted at day 10.5 dpc, when PAI-1 is normally expressed by the trophoblasts, in an enlarged decidua and a reduced labyrinth layer due to trophoblast cells differenciation delay as evidenced by Ki-67 immunostaining. Similar results were also described with cystein cathepsin proteases in trophoblast function (47) . Moreover, both maternal and foetal vessel densities were decreased. Prolactin immunohistochemistry revealed no difference in trophoblast giant cells density between PAI-1 +/+ and PAI-1 -/-mice (data not shown). At later time point (14.5 dpc) a normalization of placental morphology was evident. Such a normalization detected at a time when PAI-1 is no longer expressed in normal mouse pregnancy indicates that placental remodeling and embryo growth become subsequently independent from PAI-1 status.
These data emphasize the importance of PAI-1 specifically at early steps of angiogenesis onset.
They are on line with previous studies related to cancer progression (36) .
PAI-1 is a multifunctional molecule known to control not only extracellular matrix proteolysis, but also cell matrix interaction through binding to vitronectin and cell surface molecules such as integrins and uPA receptor (7; 15; 18; 43) . We previously showed in various in vivo and in vitro models of angiogenesis that PAI-1 plays a critical angiogenic role mainly through its capacity to tightly control extracellular proteolysis (4) . Although, PAI-1 action could rely on the control of plasmin-mediated proteolysis, the absence of a phenotype in plasminogen-deficient mice suggests that the action of PAI-1 could not be simply related to this mechanism. In an attempt to determine whether impaired vascularisation in the labyrinth layer could be related to excessive extracellular matrix protein deposit, immunostainings of fibrin(ogen), collagen III and collagen VI were performed. However, no difference between the two genotypes of mice was detected (data not shown). Moreover, in both physiological (the present work) and pathological angiogenesis process, the phenotype associated to PAI-1 deficiency (impaired angiogenesis) is more severe than that observed in plasminogendeficient mice. Indeed, the defect of tumor vascularisation observed in PAI-1 -/-mice could not be fully phenocopied by plasminogen deficiency(3) . Therefore, one can suggest that PAI-1controls placenta formation by regulating adhesive, migratory, and growth properties of invasive cells (15; The number of implantation sites analyzed is indicated in each graph (n). 
